MDT

89.25

-0.49%↓

VEEV

279.43

-1.02%↓

A

113.17

-5.79%↓

WBA

11.5

-0.09%↓

HQY

96.22

-1.19%↓

MDT

89.25

-0.49%↓

VEEV

279.43

-1.02%↓

A

113.17

-5.79%↓

WBA

11.5

-0.09%↓

HQY

96.22

-1.19%↓

MDT

89.25

-0.49%↓

VEEV

279.43

-1.02%↓

A

113.17

-5.79%↓

WBA

11.5

-0.09%↓

HQY

96.22

-1.19%↓

MDT

89.25

-0.49%↓

VEEV

279.43

-1.02%↓

A

113.17

-5.79%↓

WBA

11.5

-0.09%↓

HQY

96.22

-1.19%↓

MDT

89.25

-0.49%↓

VEEV

279.43

-1.02%↓

A

113.17

-5.79%↓

WBA

11.5

-0.09%↓

HQY

96.22

-1.19%↓

Search

Atossa Genetics Inc

Uždarymo kaina

0.91 -2.15

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

0.88

Max

0.94

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-371K

-6.7M

Darbuotojai

15

EBITDA

-766K

-7.1M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+498.94% upside

Dividendai

By Dow Jones

Kitas uždarbis

2025-08-11

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

13M

121M

Ankstesnė atidarymo kaina

3.06

Ankstesnė uždarymo kaina

0.91

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Bullish Evidence

Atossa Genetics Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-07-15 23:41; UTC

Rinkos pokalbiai

Nikkei May Trade in Range Amid Tariff Uncertainty -- Market Talk

2025-07-15 23:40; UTC

Rinkos pokalbiai

Gold Edges Higher on Possible Position Adjustments -- Market Talk

2025-07-15 23:05; UTC

Rinkos pokalbiai

Auckland International Airport Passenger Growth May Disappoint Again -- Market Talk

2025-07-15 21:36; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2025-07-15 21:36; UTC

Rinkos pokalbiai

Canada CPI Data Fuel Rate-Prediction Revisions -- Market Talk

2025-07-15 20:50; UTC

Rinkos pokalbiai

Tech, Media & Telecom Roundup: Market Talk

2025-07-15 20:50; UTC

Rinkos pokalbiai
Uždarbis

Financial Services Roundup: Market Talk

2025-07-15 20:50; UTC

Rinkos pokalbiai

Auto & Transport Roundup: Market Talk

2025-07-15 20:50; UTC

Rinkos pokalbiai

Health Care Roundup: Market Talk

2025-07-15 20:14; UTC

Įsigijimai, susijungimai, perėmimai

Chinese EV Makers to Combine. Geely Is Buying Zeekr. -- Barrons.com

2025-07-15 20:07; UTC

Uždarbis

BlackRock Shares Tumble After Big Client Redemption Blunts Quarterly Results -- Update

2025-07-15 20:06; UTC

Rinkos pokalbiai

Nvidia, AMD Seen Benefiting from Return to Chinese Chip Sales -- Market Talk

2025-07-15 19:54; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2025-07-15 19:54; UTC

Rinkos pokalbiai

Meta CEO Hints at Higher Revenues, Expenses With Data Center Plans -- Market Talk

2025-07-15 19:38; UTC

Rinkos pokalbiai

Oil Falls As Eventual Oversupply Concerns Weigh -- Market Talk

2025-07-15 19:09; UTC

Rinkos pokalbiai

U.S. Natural Gas Futures Post Back-to-Back Gains -- Market Talk

2025-07-15 19:07; UTC

Rinkos pokalbiai

Canada CFOs Willing to Take Risks, Increase Spending -- Market Talk

2025-07-15 19:03; UTC

Rinkos pokalbiai

Gold Slips as Big Buyers Pull Back -- Market Talk

2025-07-15 18:32; UTC

Įsigijimai, susijungimai, perėmimai

Waters Corp. Deal for Becton Dickinson Unit a Long-Term Play With Some Risks -- Analysis

2025-07-15 18:31; UTC

Įsigijimai, susijungimai, perėmimai

Waters Deal for Becton Unit Pairs Near-Term Risks With Possible Long-Term Rewards, Analysts Say

2025-07-15 18:13; UTC

Rinkos pokalbiai

Canada Adopts 'Note of Realism' in US Trade Talks, Setting Stage for Possible Tariff Deal -- Market Talk

2025-07-15 17:40; UTC

Rinkos pokalbiai

Canadian Inflation Adds to Case for Bank of Canada Extending Pause -- Market Talk

2025-07-15 17:40; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2025-07-15 17:25; UTC

Įsigijimai, susijungimai, perėmimai

National Fuel Gas Gets Rare Double Upgrade. Buy the Stock, Analyst Says. -- Barrons.com

2025-07-15 17:24; UTC

Rinkos pokalbiai

Dollar Gains Strength After Inflation Data -- Market Talk

2025-07-15 16:49; UTC

Rinkos pokalbiai

Oil Futures Likely to Continue Sideways Trade -- Market Talk

2025-07-15 16:20; UTC

Rinkos pokalbiai
Uždarbis

Financial Services Roundup: Market Talk

2025-07-15 16:20; UTC

Rinkos pokalbiai

Auto & Transport Roundup: Market Talk

2025-07-15 16:20; UTC

Rinkos pokalbiai

Health Care Roundup: Market Talk

2025-07-15 15:42; UTC

Rinkos pokalbiai

Coca-Cola Seen as Top Pick Ahead of Consumer Staples Earnings -- Market Talk

Akcijų palyginimas

Kainos pokytis

Atossa Genetics Inc Prognozė

Kainos tikslas

By TipRanks

498.94% į viršų

12 mėnesių prognozė

Vidutinis 5.63 USD  498.94%

Aukščiausias 7.5 USD

Žemiausias 4 USD

Remiantis 4 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Atossa Genetics Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

4 ratings

4

Pirkti

0

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

0.7955 / 0.898Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Bullish Evidence

Vidutinės trukmės periodas

Strong Bullish Evidence

Ilgalaikis periodas

Weak Bearish Evidence

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Atossa Genetics Inc

Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops medicines in the areas of unmet medical need in oncology for women breast cancer and other conditions in the United States. The company's lead drug candidate is oral (Z)-endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It also develops immunotherapy/chimeric antigen receptor therapy programs. The company was formerly known as Atossa Genetics Inc. and changed its name to Atossa Therapeutics, Inc. in January 2020. Atossa Therapeutics, Inc. was founded in 2008 and is headquartered in Seattle, Washington.